株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

心臓のための健康成分の世界市場

Heart Health Ingredients

発行 Global Industry Analysts, Inc. 商品コード 252319
出版日 ページ情報 英文 456 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
心臓のための健康成分の世界市場 Heart Health Ingredients
出版日: 2012年08月01日 ページ情報: 英文 456 Pages
概要

当レポートでは、世界の心臓のための健康成分市場について調査分析を行い、オメガ3PUFA、大豆タンパク、植物ステロール、ベータグルカゴン、その他の各製品部門にまとめるとともに、米国、カナダ、日本、欧州、アジア太平洋地域、世界のその他の諸国の各市場について包括的に分析し、将来の見通し、過去6年間の実績、主要企業のプロファイルなどについてまとめ、概略下記の構成で取り上げております。

第1章 イントロダクション、調査方法、製品の定義

第2章 エグゼクティブサマリー

  • 産業の概要
    • 健康への関心が機能性食品市場を促進
    • 今後の成長促進因子
    • 研究開発動向
    • 現在と将来の分析
    • 市場動向
    • 心臓疾患:市場促進の主な要因
    • 「心臓の健康」市場は安定成長
    • PUFA
    • オメガ3脂肪酸のアジア太平洋市場での成長
    • 市場見通しの明るさから新規参入が急増
    • 植物ステロール市場の成長
    • 自然成分
    • 栄養学
    • スナックの健康表示
    • アジア太平洋地域市場
    • アジア太平洋地域のオメガ3市場の成長
    • 世界の心臓のための健康成分市場を独占する大豆タンパク
    • ビタミン強化製品
    • 天然ビタミンE
    • 成長の障害
    • 主な成長抑制因子
    • 規制の問題
    • 主な統計
  • 心臓疾患の概要
  • 製品の概要
    • イントロダクション
    • 機能性食品の定義
    • 心臓のための健康成分とは?
    • 食物成分と心臓の健康への効果
    • 主な心臓のための健康成分
    • オメガ3PUFA
    • 大豆タンパク
    • 植物ステロール
    • ベータグルカゴン
    • その他
  • 製品の発売
  • 最近の産業活動
  • 世界の主要企業
  • 世界市場の概要

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • その他の欧州諸国
  • アジア太平洋地域
  • 世界のその他の諸国

第4章 競合状況

目次
Product Code: MCP-6752

This report analyzes the worldwide markets for Heart Health Ingredients in US$ Million by the following Product Segments: Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 56 companies including many key and niche players such as Archer Daniels Midland Company, BASF SE, BioActives, LLC, Biovelop AB, Cargill, Inc., Cyanotech Corporation, DSM Nutritional Products Limited, Glanbia Nutritionals, Inc., Lonza Group Limited, LycoRed Limited, Martek Biosciences Corporation, Novus Nutrition Brands, LLC, Ocean Nutrition Canada Limited, Omega Protein Corporation, Pharmachem Laboratories, Inc., Proprietary Nutritionals, Inc., Raisio plc, Solae Europe, S.A., Soy Labs, LLC, and Valensa International, LLC. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Omega-3 PUFA
    • Soy Protein
    • Phytosterols
    • Beta-Glucagons
    • Other Heart Health Ingredients

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Health Consciousness Driving the Market for Functional Foods
  • Future Growth Stimulators
  • Research & Development: Determines the Future of Health Ingredients
  • Current & Future Analysis
  • Market Trends
  • Cardiovascular Disorders - The Leading Cause for Flourishing Heart Health Ingredients Market
  • "Heart Health" Growing on a Healthy Note
  • PUFA - A Part of Regular Diet
  • Omega-3 Fatty Acids Adding Flavor to Heart Health Ingredients Markets
  • Lucrative Prospects Call for a Flood of New Entrants
  • Phytosterols Market on a Growth Trajectory
  • Natural Ingredients - The In thing
  • Nutrition Science: An Evolutionary Proof
  • Health Claims on Snacks - Opportunity Galore
  • Asia Pacific - A Threat to Established Markets
  • Omega-3 Market in Asia-Pacific Expected to Witness Robust Growth Momentum
  • Soy Protein Dominates Global Heart Health Ingredients Market
    • Soy Foods & Beverages: A Boon
    • Aging Population Propels Soyfood Sales
  • Vitamin Enriched Products: Boosting Market Growth
  • Natural Vitamin E - A Cross-Sectional Exposition
  • Stumbling Blocks
  • Major Growth Delimiters
  • Regulation Issues
  • Key Statistics
    • Table 1: Leading Beverage Launches with Heart Health Claims (2011): Percentage Share Breakdown for Dairy Drinks, Tea, Dairy Alternative Drinks and Others (includes corresponding Graph/Chart)
    • Table 2: Leading Heart Health Ingredients in Global Market (2011): Percentage Breakdown for Vitamin E, Phytosterols, Soy Protein, Magnesium, Niacin, Omega-3, Flaxseed and Others in Beverage Launches with Heart Health Claims (includes corresponding Graph/Chart)

2. OVERVIEW OF CARDIOVASCULAR DISEASES

  • CVD - Global Facts
    • Table 3: Leading Countries with Total Deaths due to Cardiovascular Diseases for 65+ Population by Sex in Thousands for the Year 2008 (includes corresponding Graph/Chart)
    • Table 4: Percentage Share of Deaths for 65+ Population due to Heart Diseases by Disease Type for Ischaemic, Cerebrovascular, Hypertensive, Inflammatory and Rheumatic in 2008 (includes corresponding Graph/Chart)

3. PRODUCT OVERVIEW

  • Introduction
  • Functional Foods - Definition
  • What are Heart Health Ingredients?
  • Food Components and Heart Health Benefit(s)
  • Select Heart Health Ingredients
  • Omega-3 PUFA
  • Soy Protein
    • Soy Protein Concentrate
    • Soy Protein Isolates
    • Textured Soy Protein (TSP)
  • Phytosterols
    • Table 5: Phytosterol Content in Select Products
  • Beta-Glucagons
  • Other Heart Health Ingredients
    • Psyllium (Fiber)
    • Coenzyme Q10
    • Vitamin C and E
    • Carotenoids
      • Astaxanthin
      • Beta-Carotene
      • Lutein
      • Lycopene
    • Niacin
    • Vitamin K2
    • Potassium
    • Magnesium
    • Selenium
    • Vitamin B12 and Folic Acid

4. PRODUCT LAUNCHES

  • Oatworks Unveils New Oat-and-Fruit Smoothies Line
  • Morinda Bioactives Commences Shipments of New Fit Body Composition Supplements
  • Danisco Launches PinVita Phytosterols
  • Danone Releases Danacol® Yoghurt in Canada
  • DSM Nutritional Products to Unveil life'sDHA™
  • ImmunoMedic Introduces Betox-93™ Glucan Ingredient
  • Nordic Naturals Launches Omega-3 Effervescent
  • Frutarom Rolls Out Benolea® Olive Leaf Extract
  • Fortitech Europe Unveils Premixes for Energy, Sports and Heart Health Nutrition
  • Sabinsa Launches pTeroWhite® and Silbinol® Ingredients
  • Oatly to Launch Oatly Fresh Drink
  • Solbar Unveils Bontex Soy Proteins in France
  • Stratum Nutrition Introduces ARTINIA™
  • Valensa International and Aker BioMarine Co-Launch Deep Ocean Krill Ingredient
  • Sara Lee Introduces Sara Lee Soft & Smooth Plus Made with DHA Omega-3 for Kids
  • Hormel Foods Introduces Omega-3/CoQ10 Combination Ingredient
  • Solae Europe Unveils FIBRIM 1270
  • Biovelop Introduces PromOat™
  • DSM Nutritional Products Showcases Heart Health Ingredients
  • Cargill Unveils Clear Valley
  • Triarco Industries Launches Aqua 10®
  • Ocean Nutrition Canada Introduces MEG-3® Dry Powder
  • Valensa International Introduces Omega Joe ALA
  • Parmalat Canada Unveils Astro BioBest Plant Sterols Yoghurt in Canada
  • Cargill Launches Vitafusion HeartOne Gummy Vitamins
  • Adam Food Ingredients Launches Range of Nutritional Ingredients
  • Bayer Consumer Care Introduces Citracal Calcium Plus Heart Health
  • Carbery Ingredients Unveils Omega-3/WPC Blend
  • BioActives Unveils Cardio HB Ingredient
  • Kashi Company Launches Plant Sterol-Fortified Crackers
  • Proprietary Nutritional Introduces Microencapsulated Version of Omega-3 Ingredients
  • Cyanotech Introduces Hawaiian Spirulina Pacifica Multivitamin Range
  • Forbes Medi-Tech Launches Reducol™-Fortified Pineapple Juice in the Philippines
  • Mitake Food Develops Beta Glucan Rich Flour
  • Natunola Health Biosciences Introduces Natunola® health's delight Omega-3 Instant Oatmeal with Shelled Flax
  • Cargill Unveils Heart Health Products
  • Soy Labs Introduces Lunasin-based Ingredients

5. RECENT INDUSTRY ACTIVITY

  • DuPont Takes Over Solae
  • BASF Acquires Equateq
  • CHS Takes Over Solbar Industries
  • Stratum Nutrition Enters into Exclusive Partnership with Phytonet
  • Enzymotec Receives Patent for Omega-Sterols in Australia
  • Atrium Innovations Acquires Minami Nutrition
  • Lactalis Iberia Purchases Stake in Biosearch Life Division of Ebro Foods
  • Royal DSM Purchases Martek Biosciences
  • Stepan Company Takes Over Certain Product Lines of Lipid Nutrition
  • Danisco BioActives Inks Long-Term Agreement with Arboris
  • Biovelop Inks Distribution Agreement with Quadra Chemicals
  • Corazonas Foods Enters into Partnership with Cargill
  • Biovelop Inks Distribution Agreement with CJP Chemicals
  • Stratum Nutrition Enters into Exclusive Partnership with CK Nutritional Ingredients
  • Valens Secures Positive EFSA Opinion for Reduchol
  • Scoular Signs Distribution Agreement with Soy Labs
  • Smart Balance Selects CoroWise Plant Phytosterols by Cargill for Heart Right Milk
  • Proprietary Nutritionals Substantiates Advertising Claims for Sytrinol Product
  • Cargill and BASF Enter into Partnership to Develop Plant-Based Omega-3 Oils
  • Hans-Gunter Berner Chooses PromOat™ Beta Glucan from Biovelop for Cellagon Aurum®
  • Genosa Receives Positive Claim from EFSA Panel
  • Mannatech Concludes Reformulation of Omega-3 Supplements
  • Stratum Nutrition Secures Generally Recognized As Safe Designation for ARTINIA Fiber Ingredient
  • Provexis and DSM Nutritional Products Ink Development Agreement for Casein Ingredient
  • ADM Inks Global Licensing Deal with Burcon NutraScience
  • Omega Protein Takes Over Cyvex Nutrition
  • BASF Purchases Cognis Holding
  • Pharmachem Laboratories Buys Forbes Medi-Tech
  • Solazyme Inks Joint Venture Agreement with Roquette Freres
  • Stratum Nutrition and Kitozyme Enter into Partnership
  • Ceapro Inks Distribution and License Agreement with Oat Cosmetics
  • Martek Biosciences Signs Agreement with Mengniu
  • Novus International Establishes Stratum Nutrition Division
  • Cognis Licenses Product Candidates from InterMed Discovery
  • Neptune Technologies' Bioressources Receive EFSA Approval for Neptune Krill Oil

6. FOCUS ON SELECT GLOBAL PLAYERS

  • Archer Daniels Midland Company (US)
  • BASF SE (Germany)
  • BioActives, LLC (US)
  • Biovelop AB (Sweden)
  • Cargill, Inc. (US)
  • Cyanotech Corporation (US)
  • DSM Nutritional Products Limited (Switzerland)
  • Glanbia Nutritionals, Inc. (US)
  • Lonza Group Limited (Switzerland)
  • LycoRed Limited (Israel)
  • Martek Biosciences Corporation (US)
  • Novus Nutrition Brands, LLC (US)
  • Ocean Nutrition Canada Limited (Canada)
  • Omega Protein Corporation (US)
  • Pharmachem Laboratories, Inc. (US)
  • Proprietary Nutritionals, Inc. (US)
  • Raisio plc (Finland)
  • Solae Europe, S.A. (Switzerland)
  • Soy Labs, LLC (US)
  • Valensa International, LLC (US)

7. GLOBAL MARKET PERSPECTIVE

    • Table 6: World Recent Past, Current and Future Analysis for Heart Health Ingredients by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 7: World Historic Review for Heart Health Ingredients by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 8: World 15-Year Perspective for Heart Health Ingredients by Geographic Region - Percentage Breakdown of Dollar Sales for Markets for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 9: World Recent Past, Current and Future Analysis for Omega-3 PUFA by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 10: World Historic Review for Omega-3 PUFA by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 11: World 15-Year Perspective for Omega-3 PUFA by Geographic Region - Percentage Breakdown of Dollar Sales for Markets for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 12: World Recent Past, Current and Future Analysis for Soy Protein by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 13: World Historic Review for Soy Protein by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 14: World 15-Year Perspective for Soy Protein by Geographic Region - Percentage Breakdown of Dollar Sales for Markets for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 15: World Recent Past, Current and Future Analysis for Phytosterols by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 16: World Historic Review for Phytosterols by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 17: World 15-Year Perspective for Phytosterols by Geographic Region - Percentage Breakdown of Dollar Sales for Markets for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 18: World Recent Past, Current and Future Analysis for Beta-Glucagon by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 19: World Historic Review for Beta-Glucagon by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 20: World 15-Year Perspective for Beta-Glucagon by Geographic Region - Percentage Breakdown of Dollar Sales for Markets for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 21: World Recent Past, Current and Future Analysis for Other Heart Health Ingredients by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 22: World Historic Review for Other Heart Health Ingredients by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 23: World 15-Year Perspective for Other Heart Health Ingredients by Geographic Region - Percentage Breakdown of Dollar Sales for Markets for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • US Heart Health Market Driven by Approvals
    • Increasing Number of Ingredients Qualify for Health Claims
    • Table 24: Leading Heart Health Ingredients in US Market (2011): Percentage Breakdown for Vitamin E, Magnesium, Omega-3, Grape Seed Extract, Phytosterols, Soy Protein and Others in Beverage Launches with Heart Health Claims (includes corresponding Graph/Chart)
    • Factors Driving Growth
    • Market Inhibitors
    • Cardiovascular Diseases Scenario
    • Table 25: Leading Causes of Death in the US (2008): Percentage Share Breakdown by Disease for Heart Disease, Cancer, Chronic Lower Respiratory Diseases, Cerebrovascular Diseases (Stroke), Alzheimer's Disease and Others (includes corresponding Graph/Chart)
    • Table 26: Deaths from Cardiovascular Diseases in the US (2008): Percentage Share Breakdown by Disease for CHD, Stroke, Hypertensive Diseases, Heart Failure (Underlying), Diseases of Arteries and Other CVD (includes corresponding Graph/Chart)
    • Table 27: Prevalence of Cardio Vascular Diseases in the US (2008): Percentage Share Breakdown by Disease for Hypertension, CHD, Angina Pectoris, Peripheral Arterial Disease, Acute Myocardial Infarction (AMI), Stroke, Heart Failure, Atrial Fibrillation and Congenital Heart Defects (includes corresponding Graph/Chart)
    • Table 28: Economic Cost on Cardiovascular Diseases in the US (2008): Expenditure for Direct and Mortality in US$ Billion (includes corresponding Graph/Chart)
    • Regulatory Environment
      • Food and Drug Administration (FDA)
      • Generally Recognized As Safe (GRAS)
      • Consumer Health Information for Better Nutrition Initiative (CHIBNI)
      • Dietary Supplement Health and Education Act (DSHEA)
      • Functional Foods and Dietary Supplements: Comparison of Regulations
      • Federal Trade Commission (FTC)
      • Nutrition Labeling and Education Act (NLEA)
      • FDA Modernization Act (FDAMA)
    • Product Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 29: US Recent Past, Current and Future Analysis for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 30: US Historic Review for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 31: US 15-Year Perspective for Heart Health Ingredients by Product Segment - Percentage Breakdown of Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current & Future Analysis
    • Regulatory Scenario
      • Definition
      • Food and Drugs Act and Health Canada
      • Natural Health Product Regulations
    • Product Launches
    • Strategic Corporate Developments
    • Ocean Nutrition Canada Limited - A Major Omega-3 Dha/Eha Supplier in Canada
  • B. Market Analytics
    • Table 32: Canadian Recent Past, Current and Future Analysis for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 33: Canadian Historic Review for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 34: Canadian 15-Year Perspective for Heart Health Ingredients by Product Segment - Percentage Breakdown of Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current & Future Analysis
    • Outlook
    • Growth Drivers
    • Regulatory Environment
      • Definition
      • FOSHU (Foods For Specified Health Uses)
  • B. Market Analytics
    • Table 35: Japanese Recent Past, Current and Future Analysis for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 36: Japanese Historic Review for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 37: Japanese 15-Year Perspective for Heart Health Ingredients by Product Segment - Percentage Breakdown of Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
      • Analysis by Country/Region
      • Analysis by Product Segment
    • Market Overview
    • Changing Demographics to Propel Market Growth
    • Growth Drivers
    • Growth Restraints
    • Heart Health - The New Functional Dairy Target
    • Death Rate Due to CVD
    • Table 38: Leading European Countries with Deaths due to Cardiovascular Diseases for the Year 2009 (Deaths per 100,000 Inhabitants) (includes corresponding Graph/Chart)
    • Regulatory Scenario
      • European Food Safety Authority (EFSA)
      • Hydroxytyrosol Bags Health Claim Approval from EFSA
  • B. Market Analytics
    • Table 39: European Recent Past, Current and Future Analysis for Heart Health Ingredients by Country/Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 40: European Historic Review for Heart Health Ingredients by Country/Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 41: European 15-Year Perspective for Heart Health Ingredients by Country/Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, and Rest of Europe Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 42: European Recent Past, Current and Future Analysis for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 43: European Historic Review for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 44: European 15-Year Perspective for Heart Health Ingredients by Product Segment - Percentage Breakdown of Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • High Incidence of 'Bad' Cholesterol Pumps Sales of Functional Fats
    • Product Launch
  • B. Market Analytics
    • Table 45: French Recent Past, Current and Future Analysis for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 46: French Historic Review for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 47: French 15-Year Perspective for Heart Health Ingredients by Product Segment - Percentage Breakdown of Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • BASF SE - A Major German Player
  • B. Market Analytics
    • Table 48: German Recent Past, Current and Future Analysis for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 49: German Historic Review for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 50: German 15-Year Perspective for Heart Health Ingredients by Product Segment - Percentage Breakdown of Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 51: Italian Recent Past, Current and Future Analysis for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 52: Italian Historic Review for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 53: Italian 15-Year Perspective for Heart Health Ingredients by Product Segment - Percentage Breakdown of Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Rising Health Concerns Make Consumers Clamor for Functional Foods
    • Growth Drivers
    • Growth Restraints
    • Regulatory Environment
    • Product Launch
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 54: UK Recent Past, Current and Future Analysis for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 55: UK Historic Review for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 56: UK 15-Year Perspective for Heart Health Ingredients by Product Segment - Percentage Breakdown of Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4e. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launches
    • Strategic Corporate Developments
    • Focus on Select Regional Players
  • B. Market Analytics
    • Table 57: Rest of Europe Recent Past, Current and Future Analysis for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 58: Rest of Europe Historic Review for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 59: Rest of Europe 15-Year Perspective for Heart Health Ingredients by Product Segment - Percentage Breakdown of Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Regulatory Scenario in the Asia-Pacific Region
    • India
      • Market Scenario
      • Soy Proteins Witness Robust Demand among Indian Consumers
    • Product Launch
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 60: Asia-Pacific Recent Past, Current and Future Analysis for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 61: Asia-Pacific Historic Review for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 62: Asia-Pacific 15-Year Perspective for Heart Health Ingredients by Product Segment - Percentage Breakdown of Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launch
    • Strategic Corporate Development
    • Lycored Limited - A Major Israeli Player
  • B. Market Analytics
    • Table 63: Rest of World Recent Past, Current and Future Analysis for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 64: Rest of World Historic Review for Heart Health Ingredients by Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 65: Rest of World 15-Year Perspective for Heart Health Ingredients by Product Segment - Percentage Breakdown of Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart Health Ingredients Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top